Form 4 Tracker
NEKTAR THERAPEUTICS
NKTR

17 insider filings · Latest: Sep 23, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 19, 2025Feb 19 8:18 PMZalevsky Jonathan
Proposed Sale
10,300$1.01$10.4K—

View →

Dec 24, 2024Dec 26 2:35 PMWilson Mark Andrew
Proposed Sale
16,560$0.8938$14.8K—

View →

Dec 23, 2024Dec 23 8:21 PMWilson Mark Andrew
Proposed Sale
33,402$0.8951$29.9K—

View →

Dec 19, 2024Dec 19 8:12 PMZalevsky Jonathan
Proposed Sale
51,115$0.9403$48.1K—

View →

Dec 18, 2024Dec 18 9:17 PMROBIN HOWARD W
Proposed Sale
85,035$0.9907$84.2K—

View →

Dec 17, 2024Dec 17 8:29 PMROBIN HOWARD W
Proposed Sale
46,995$1.01$47.3K—

View →

Nov 19, 2024Nov 19 9:10 PMZalevsky Jonathan
Proposed Sale
7,785$1.01$7.9K—

View →

Nov 19, 2024Nov 19 8:28 PMWilson Mark Andrew
Proposed Sale
6,407$1.01$6.5K—

View →

Nov 19, 2024Nov 19 8:17 PMROBIN HOWARD W
Proposed Sale
16,278$1.01$16.5K—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 23, 2026Sep 26 12:29 AMRoy A WhitfieldDirector
Grant/Award
4,000$57.664,000(D)

View →

Sep 23, 2026Sep 26 12:26 AMScott R GreerDirector
Grant/Award
4,000$57.664,000(D)

View →

Sep 23, 2026Sep 26 12:22 AMRobert ChessDirector
Grant/Award
4,000$57.664,000(D)

View →

Sep 23, 2026Sep 26 12:20 AMDiana BrainardDirector
Grant/Award
4,000$57.664,000(D)

View →

Sep 23, 2026Sep 26 12:18 AMJeffrey Robert AjerDirector
Grant/Award
4,000$57.664,000(D)

View →

Jul 24, 2026Jul 24 10:35 PMJonathan ZalevskyChief R&D Officer
Grant/Award
16,500$15.1516,500(D)

View →

Jul 24, 2026Jul 24 10:34 PMHoward W RobinDirector, President & CEO
Grant/Award
57,200$15.1557,200(D)

View →